Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. MyRXCash
WARNING LETTER
•MyRXCash

MyRXCash – FDA Warning Letter

Record Details

The FDA issued a Warning Letter to MyRXCash after reviewing their websites, which offer unapproved new drugs and misbranded drugs for sale to U.S. consumers, violating sections 301(a), 301(d), 503(b), and 505(a) of the FD&C Act.

Specifically, the websites market "tramadol 50 mg/ml" oral solution, which is an unapproved new drug under section 201(p) and 505(a) of the FD&C Act because no FDA-approved applications are in effect for this specific formulation. While FDA-approved tramadol exists in tablet/capsule form, it carries a boxed warning due to risks like addiction, respiratory depression, and neonatal opioid withdrawal syndrome.

Furthermore, "tramadol 50 mg/ml" is a misbranded drug under section 502(f)(1) and 503(b)(1)(A) of the FD&C Act because, as a prescription product, it lacks adequate directions for layperson use and is not amenable to self-diagnosis and treatment. Its unapproved status also means it's not exempt from misbranding requirements.

The FDA emphasizes the inherent risk to consumers from unapproved and misbranded drugs, citing concerns about safety, effectiveness, contamination, and the opioid epidemic. MyRXCash is required to immediately cease marketing violative

Company
MyRXCash
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas (TJ) Christl (Office Director)
View Company Profile

ID · 92ae5ed2-de32-4635-8bfe-01cea528a24a

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 331(d)21 U.S.C. 353(b)21.U.S.C. 355(a)21 U.S.C. 321(p)21 CFR 201.521 CFR 201.11521 U.S.C. 352(f)(1)21 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MyRXCash
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.